Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
Public ClinicalTrials.gov record NCT00789698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety and Efficacy of Lurasidone in Subjects With Schizophrenia (PEARL 3 Extension Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR long term among schizophrenic outpatients with chronic schizophrenia.
Study identification
- NCT ID
- NCT00789698
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Jun 30, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Jun 11, 2015
2008 – 2011
United States locations
- U.S. sites
- 27
- U.S. states
- 10
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K&S Professional Research Services, LLC | Little Rock | Arkansas | 72201 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Comprehensive Neuroscience, Inc | Cerritos | California | 90703 | — |
| Clinical Innovations, Inc. | Costa Mesa | California | 92647 | — |
| Synergy Escondido,710 East Grand Ave. | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network Inc | Garden Grove | California | 92645 | — |
| Apostle Clinical Trials, Inc. | Long Beach | California | 90813 | — |
| California Clinical Trials | Paramount | California | 90723 | — |
| Pasadena Research Institute | Pasadena | California | 91107 | — |
| CNRI - Los Angeles LLC,8309 Telegraph Road | Pico Rivera | California | 90660 | — |
| CNRI- LOs Angeles, LLC | Pico Rivera | California | 90660 | — |
| Clinical Innovations, Inc. | Riverside | California | 92647 | — |
| CNRI - San Diego | San Diego | California | 92102 | — |
| UCSD Medical Drive | Sandeigo | California | 92103 | — |
| Segal Institute for Clinical Research | Highlands Ranch | Colorado | 80103 | — |
| Comprehensive Neuroscience, Inc. | Washington D.C. | District of Columbia | 20016 | — |
| Florida Clinical Research Center LLC | Bradenton | Florida | 34208 | — |
| Lake Charles Clinical Trials LLC,2770 3rd Avenue,Suite 340 | Lake Charles | Louisiana | 70601 | — |
| Booker, J. Gary, MD. APMC | Shreveport | Louisiana | 71104 | — |
| St. Charles Psychiatric Associates | Saint Charles | Missouri | 63301 | — |
| St. Louis Research, Inc. | St Louis | Missouri | 63118 | — |
| CRI Worldwide | Willingboro | New Jersey | 08046 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11238 | — |
| Comprehensive Neuroscience, Inc | Holliswood | New York | 11423 | — |
| Community Clinical Research | Austin | Texas | 78729 | — |
| FutureSearch Clinical Trials, LLC. | Austin | Texas | 78756 | — |
| Pillar Clinical Research | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00789698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2015 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00789698 live on ClinicalTrials.gov.